- Price
- $81.51
- Day
- +0.06%
- Mkt Cap
- $10.99B
- 52W Range
- $52.68 – $101.40
- Volume
- 995.1K
- Beta
- 0.95
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Globus Medical will report Q2 results on Aug. 6. Investors will be keen to know whether Enabling Technologies and Spine strength aid revenue & earnings growth.
Read full article
American Capital Management Inc. grew its stake in Globus Medical, Inc. (NYSE: GMED) by 36.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 663,049 shares of the medical device company's stock after purchasing an additional 176,837 shares during the period.
Read full article
NEW YORK, July 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.
Read full article
Dimensional Fund Advisors LP raised its stake in Globus Medical, Inc. (NYSE: GMED) by 2.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,769,897 shares of the medical device company's stock after purchasing an additional 33,976 shares during the
Read full article
Bank of New York Mellon Corp lessened its holdings in Globus Medical, Inc. (NYSE: GMED) by 1.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 742,551 shares of the medical device company's stock after selling 10,681 shares during the period. Bank of
Read full article
GMED is gaining share in musculoskeletal solutions with strong implant and trauma growth, backed by a debt-free balance sheet despite cost and FX pressures.
Read full article
When investors think of the health care sector, most imagine the stability of pharmaceutical giants or the high-risk/high-reward profile of up-and-coming clinical stage drug developers. Medical device companies operate within a unique ecosystem and are often easy to overlook.
Read full article
Globus Medical's 43.6% one-year rally is fueled by strong growth across both business segments, rising technology adoption and a debt-free balance sheet.
Read full article
AUDUBON, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2026 after the market close on Thursday, August 6, 2026.
Read full article
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Read full article
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article